Enleofen

Enleofen Develops Innovative, Safe, and Efficient Treatments to Address Today's Biggest Healthcare Challenges. The company is developing novel anti-fibrotic therapies based on breakthrough science. Enleofen aims to use its antibodies in clinical trials within two years, with the goal of developing a drug that can be used to treat a variety of diseases that currently have no treatment options.